Denice Spero ’88 PhD, president and chief business officer of ProThera Biologics, announced the company had entered into a licensing agreement with Takeda Pharmaceuticals to develop plasma-derived therapies for the treatment of acute inflammatory conditions. ProThera was co-founded by Yow-Pin Lim and Douglas Hixson, faculty members at Brown’s Warren Alpert Medical School.
See more notes:
GS Class of 1988